<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31683">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01784718</url>
  </required_header>
  <id_info>
    <org_study_id>PRO12070385</org_study_id>
    <nct_id>NCT01784718</nct_id>
  </id_info>
  <brief_title>Buphenyl Therapy for Byler's Disease</brief_title>
  <official_title>Compassionate Use of BuphenylÂ® in the Treatment of Byler's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single patient compassionate use protocol to determine whether Buphenyl
      (4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.
    </textblock>
  </brief_summary>
  <overall_status>No longer available</overall_status>
  <phase>N/A</phase>
  <study_type>Expanded Access</study_type>
  <study_design>N/A</study_design>
  <condition>Byler Disease</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Buphenyl</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Byler Disease

          -  Cholestasis unresponsive to pharmacologic therapy

        Exclusion Criteria:

          -  Allergy/Hypersensitivity to Buphenyl
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 4, 2013</lastchanged_date>
  <firstreceived_date>February 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholestasis, Intrahepatic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>4-phenylbutyric acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
